Bevital

What Bevital does

Bevital AS is a non-profit service laboratory headquartered in Bergen, Norway, founded in 2003 by researchers including Per Magne Ueland, Professor emeritus at the University of Bergen. The company provides high-precision targeted metabolomics and proteomics analysis to academic institutions, contract research organizations, and pharmaceutical clients worldwide. Its service customer base spans Norway, Australia, and the United States, with named engagements including the Melbourne Collaborative Cohort Study (Cancer Council Victoria), the HUNT Research Centre at NTNU, and UPMC Hillman Cancer Center.

The company's core technology rests on LC-MS/MS and GC-MS/MS platforms combined with authentic isotope-labelled internal standards for each analyte, enabling quantification across physiologically relevant dynamic ranges from pmol/L to mmol/L in serum, plasma, CSF, and other matrices. Bevital's product surface comprises four pre-designed analytical panels (Cardiometabolic, Inflammation & Immune Activation, Microbiome, and Nutrition & Lifestyle), a customizable Mix-and-Match service, authorized Olink Proteomics (16 Target 96/48 panels plus custom Flex panels of 5–30 assays), and a multiomics data-analysis partnership with Biogenity. Quality assurance is supported by participation in five external proficiency schemes (DEKS, DEQAS, KEQAS, ERNDIM, LABQUALITY).

Commercially, Bevital operates a sales-led, professional-services model with differentiated pricing: academic and non-profit clients receive subsidized rates near cost, while commercial clients pay full-service rates with margin. Service contracts are typically multi-year, with purchase orders or grant numbers required for academic work and signed service agreements for commercial engagements. The company extends substantial value-added scientific support, including study design consultation, manuscript review, and statistical analysis. With approximately 12 staff, 579 scientific publications (2000–2026), and 20+ years of operational history, Bevital monetizes primarily through laboratory service fees with no disclosed venture or external equity ownership.

Name

Bevital

Legal name

BEVITAL AS

Website

https://bevital.no

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Bevital AS is a Norwegian non-profit metabolomics and proteomics service laboratory that delivers high-precision targeted biomarker analysis using LC-MS/MS and GC-MS/MS platforms to academic researchers, pharmaceutical clients, and epidemiologists globally.

Ownership category

akta.pro rank

Product category

Analytical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

akta.pro secondary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Targeted metabolomics services
• Proteomics analytical services
• Mass spectrometry laboratory
• Biomarker quantification services
• Multiomics research services

Headquarters

HQ city

Bergen

HQ country

Norway

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

1. Analytical Services Revenue: Bevital operates as a non-profit organization providing metabolomics and proteomics analytical services. Revenue is generated through laboratory service fees for sample analysis. Pricing differs between commercial clients (full-service pricing with profit margin) and academic/non-profit clients (subsidized pricing near cost).
2. Academic/Non-profit Services: Subsidized pricing for academic and non-profit clients to support fundamental research. Pricing covers materials, instrument usage, and labor without commercial profit margin. Requires valid purchase order or grant number.
3. Commercial Services: Full-service pricing for commercial clients including for-profit companies and contract research organizations (CROs). Includes profit margin reflecting commercial value of research services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Bevital provides high-precision targeted metabolomics and proteomics laboratory services using LC-MS/MS and GC-MS/MS platforms with authentic isotope-labelled internal standards. The company offers ready-to-run pathway panels (Cardiometabolic, Inflammation & Immune Activation, Microbiome, Nutrition & Lifestyle), customizable Mix-and-Match panels, Olink Proteomics services, and multiomics data analysis. Customers submit biological samples (serum, plasma, CSF, urine, whole blood) for analysis with results delivered as analytical reports.

Product overview

Bevital is a metabolomics and proteomics service laboratory offering a unified portfolio of targeted analytical services. The core offering consists of High-Precision Metabolomics Services utilizing LC-MS/MS and GC-MS/MS platforms, supported by four pre-designed Ready-to-Run analytical panels (Cardiometabolic, Inflammation & Immune Activation, Microbiome, and Nutrition & Lifestyle), customizable Mix-and-Match panels, Olink Proteomics services, and Biogenity Omics Analysis partnership for multiomics data integration. Bevital operates as a non-profit organization with 20+ years of experience, providing academic support including funding application assistance, manuscript review, and statistical analyses.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiometabolic Panel Targeted metabolomics panel measuring acylcarnitines, AGEs, amino acids and catabolites, ketone bodies, and TCA metabolites for assessing cardiometabolic health in research samples.
• Inflammation & Immune Activation Panel Targeted metabolomics panel measuring kynurenines and ratio-derived metabolites, neopterin, and protein markers for assessing inflammatory and immune responses in research samples.
• Microbiome Panel Targeted metabolomics panel measuring amino acid derived metabolites, choline oxidation products, indoles, and short-chain fatty acids (SCFAs) for assessing gut microbiome health in research samples.
• Nutrition & Lifestyle Panel Targeted metabolomics panel measuring B- and fat-soluble vitamins, essential amino acids, meat and fish intake biomarkers, and tobacco and coffee intake markers for nutritional and lifestyle assessment in research samples.
• Mix-and-Match Custom Panels Customized panel service allowing researchers to combine any markers from Bevital's comprehensive portfolio of metabolites, intermediates, vitamins, and co-factors to create tailored analytical panels for specific research needs, maximizing flexibility and cost-efficiency.
• Olink Proteomics Proteomics service offering 16 different Olink Target 96&48 panels and Olink Flex panels (5-30 assays per kit) for high-quality protein biomarker analysis from as little as 1 µl of sample volume. Customers can choose from approximately 200 proteins to combine into unique Olink Flex panels.
• Biogenity Omics Analysis Multiomics data analysis service delivered through partnership with Biogenity, providing biostatistics expertise, multi-omics project planning, and data integration and interpretation across transcriptomics and genomics to expand projects beyond metabolomics and proteomics.

Quantifiable outcome

• High analytical accuracy through participation in external quality control programs (DEKS, DEQAS, KEQAS, ERNDIM, LABQUALITY)
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• OlinkcoreTechnology or IntegrationBevital is an authorized service provider of Olink proteomics. Offers 16 different Olink Target 96&48 panels for high-quality proteomics from 1 µl of sample volume only. Customers can choose from about 200 proteins and combine them in unique Olink Flex panels, offering 5 to 30 assays per kit.
• BiogenitycoreStrategic or Co-development PartnerBevital partners with Biogenity, a research organization specializing in omics research and discovery. With Biogenity's expertise in biostatistics, Bevital provides seamless workflow from multi-omics project planning to data integration and interpretation. This collaboration enables customers to expand projects by incorporating transcriptomics and genomics data.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lipotype: Lipotype specializes in lipidomics using mass spectrometry for clinical and academic research. Comparable to Bevital on mass-spectrometry-based targeted analysis services for research customers, with a narrower lipid focus.
• Nightingale Health: Nightingale Health offers blood-based metabolomics and biomarker analysis for population health and clinical research. Directly comparable to Bevital on biomarker analytics for large epidemiological studies, though with a more automated, NMR-based platform.
• Olink (Thermo Fisher Scientific): Olink is the proteomics platform whose technology Bevital runs as an authorized service provider. Relevant peer because it defines the proteomics service economics and competitive context for Bevital's Olink offering.
• Human Metabolome Technologies (HMT): HMT provides CE-MS and LC-MS metabolomics services for academic and pharma research. Directly comparable as a metabolomics service laboratory serving biomedical research customers.
• BIOCRATES Life Sciences: BIOCRATES provides targeted metabolomics kits and services for clinical and research use, including mass-spectrometry-based panels. Comparable to Bevital in targeted-metabolomics scope and customer base (academic and pharma research).
• Metabolon: Metabolon is the largest commercial targeted metabolomics services provider, offering precision metabolomics across large-scale studies — directly comparable to Bevital's core offering, with broader commercial scale and broader panel coverage.

Broad incumbents

• Eurofins Scientific: Eurofins is a global testing-services conglomerate with significant metabolomics and clinical-trial-support capabilities. Overlaps with Bevital in research-grade analytical services but as part of a much broader portfolio and at much greater scale.
• Labcorp Drug Development (formerly Covance): Labcorp offers central-laboratory and biomarker-services across clinical trials, including targeted metabolomics. Comparable to Bevital on biomarker services for pharma and CROs but at substantially greater scale and broader scope.

Emerging players

• Creative Proteomics: Creative Proteomics offers metabolomics and proteomics services for research customers, including targeted panels. Comparable to Bevital on multiomics service offering but with a broader, more commercial orientation and lower price points.
• Biogenity: Biogenity is Bevital's listed partner for multiomics data analysis, biostatistics, and interpretation. Relevant as an emerging adjacent player in the same multiomics workflow that Bevital sells into.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bevital-as

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bevital